Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

BEYONDSPRING INC.

(BYSI)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su BEYONDSPRING INC.
21/10BEYONDSPRING: Initiates Mid-Stage Plinabulin Combo Trial in Lung Cancer Patients
21/10BEYONDSPRING: Announces First Patient Treated in Phase 2 Study with Plinabulin Combined w..
21/10BeyondSpring Announces First Patient Treated in Phase 2 Study with Plinabulin Combined ..
20/10BEYONDSPRING: Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabu..
20/10Beyondspring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinab..
21/09BEYONDSPRING: Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Pli..
20/09BEYONDSPRING: Shares Extend Losses in Afternoon Trading Following Plinabulin Phase 3 Data
20/09BEYONDSPRING: Plinabulin Phase 3 Study Meets Primary Endpoint; Shares Drop on Speculation..
20/09Top Midday Decliners
20/09BEYONDSPRING: Says Plinabulin Phase 3 Study Meets Primary Endpoint - Shares Slip Premarke..
20/09BEYONDSPRING: Dublin-3 (bpi-2358-103)
20/09BEYONDSPRING: Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Pli..
16/09BEYONDSPRING: Pharmaceuticals Announces New Positive Data on Plinabulin from Its Chemothe..
13/09BEYONDSPRING: Corporate Presentation
10/09BEYONDSPRING: Q2 Net Loss Widens
10/09BEYONDSPRING: Announces Second Quarter 2021 Financial Results and Provides a Corporate Up..
10/09Beyondspring Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
10/09NORTH AMERICAN MORNING BRIEFING: Stock Futures -2-
09/09BEYONDSPRING: Announces Three Poster Presentations About its Chemotherapy-Induced Neutrop..
08/09BeyondSpring to Participate in the Upcoming September Conferences
07/09BEYONDSPRING: to Provide Update on 'Recent Corporate Events' During Q2 Earnings Call -- S..
07/09BEYONDSPRING: to Host Second Quarter Financial Results and Corporate Update Conference Ca..
31/08BEYONDSPRING: Announces Late-Breaking Oral Presentation of Final Phase 3 DUBLIN-3 Data wi..
27/08BEYONDSPRING: Announces Exclusive Commercialization and Co-development Agreement with Jia..
26/08BeyondSpring Shares Up 17% After China Commercialization Deal
26/08UPDATE: BeyondSpring, Jiangsu Hengrui Pharmaceuticals Enter Agreement for Development of ..
26/08BEYONDSPRING: Jiangsu Hengrui Pharmaceuticals Enter Agreement for Development of Lung Can..
26/08BEYONDSPRING: Announces Exclusive Commercialization and Co-development Agreement with Jia..
26/08BeyondSpring Announces Exclusive Commercialization and Co-Development Agreement with Ji..
10/08BEYONDSPRING: CEO Dr. Lan Huang Named to PharmaVOICE 100 Most Inspiring People in Life Sc..
04/08SECTOR UPDATE: Health Care Stocks Unable to Sustain Midday Rise After Biotechs Fade Late
04/08SECTOR UPDATE: Health Care Stocks Rebound as Biotechs Surge
04/08Top Midday Gainers
04/08BEYONDSPRING: DUBLIN-3 Topline Data
04/08Wall Street Cautiously Lower Prebell; Stabilizing After Earnings, Data Boost
04/08SECTOR UPDATE: Health Care Stocks Mixed Premarket Wednesday
04/08SECTOR UPDATE: Health Care
04/08US Futures Flat, Stabilizing After Earnings, Data Boost
04/08Top Premarket Gainers
04/08BEYONDSPRING: Reports Positive Topline Data in Late-Stage Study of Lung Cancer Combo Drug..
04/08BEYONDSPRING: Announces Positive Topline Results from its DUBLIN-3 Registrational Trial o..
04/08BeyondSpring Announces Positive Topline Results from its DUBLIN-3 Registrational Trial ..
14/07BEYONDSPRING: Strengthens Board with the Addition of Ex-Immunomedics and Constellation Co..
14/07BeyondSpring Announces the Appointment of Brendan Delaney to Its Board of Directors
14/07BeyondSpring Strengthens Board with the Addition of Ex-Immunomedics and Constellation C..
08/07BEYONDSPRING: to Participate in the William Blair Biotech Focus Conference
25/06BEYONDSPRING INC.(NASDAQCM: BYSI) dropped from Russell Microcap Value Index
25/06BEYONDSPRING INC.(NASDAQCM: BYSI) dropped from Russell Small Cap Comp Value Index
25/06BEYONDSPRING INC.(NASDAQCM: BYSI) dropped from Russell 2500 Value Index
25/06BEYONDSPRING INC.(NASDAQCM: BYSI) dropped from Russell 3000E Value Index
25/06BEYONDSPRING INC.(NASDAQCM: BYSI) dropped from Russell 3000 Value Index
25/06BEYONDSPRING INC.(NASDAQCM: BYSI) dropped from Russell 2000 Value Index
17/06BeyondSpring to Host R&D Day to Discuss Novel Immune Agent Plinabulin's Development Pro..
17/06BEYONDSPRING: TD Ameritrade Watch List
16/06BEYONDSPRING: 2021 First Quarter Financial Report
16/06BEYONDSPRING: Reports Smaller Q1 Loss
16/06BEYONDSPRING: Announces First Quarter 2021 Financial Results and Provides a Corporate Upd..
16/06Beyondspring Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
16/06BEYONDSPRING: Announces First Quarter 2021 Financial Results and Provides a Corporate Upd..
16/06BEYONDSPRING: Earnings Flash (BYSI) BEYONDSPRING Posts Q1 Revenue $338,000
16/06Equities Wobble in Pre-Bell US Trading as Fed Meeting Awaited; Europe Mixed, Asia Slide..
16/06Wall Street Edges Forward Pre-Bell; Futures Green, Europe Higher, Asia Lower
16/06NORTH AMERICAN MORNING BRIEFING: Stock Futures -2-
11/06BeyondSpring to Host First Quarter Financial Results and Corporate Update Conference Ca..
10/06BeyondSpring Announces Final Positive Data from the PROTECTIVE-1 Phase 3 CIN Program of..
10/06BeyondSpring Announces Final Positive Data from the PROTECTIVE-1 Phase 3 CIN Program of..
08/06BEYONDSPRING: Announces a Late-Breaking Poster Presentation of PROTECTIVE-2 Phase 3 Data ..
08/06BeyondSpring Announces a Late-Breaking Poster Presentation of PROTECTIVE-2 Phase 3 Data..
07/06BEYONDSPRING: Announces Three Presentations Highlighting Positive Clinical Outcome Data f..
04/06BEYONDSPRING: Commences Dosing in Phase 1b/2 Trial of Plinabulin Combo Therapy in Advance..
04/06BeyondSpring Announces First Patient Dosed in a Triple Combination Study with Plinabuli..
04/06BeyondSpring Announces First Patient Dosed in a Triple Combination Study with Plinabuli..
02/06BEYONDSPRING: Corporate Presentation
01/06BEYONDSPRING: Infection Treatment Application Accepted, Granted Priority Review by FDA
01/06BeyondSpring Announces U.S. FDA Acceptance and Priority Review of New Drug Application ..
1  2  3  4  5Pross.
Prossimo evento su BEYONDSPRING INC.